Comac Medical Expands With ILIFE Consulting Acquisition
Deal News | May 22, 2025 | PR Newswire Cision EdgeCap Partners
Comac Medical Group, a UK-based contract research organization, acquires the Parisian company ILIFE Consulting, with backing from EdgeCap Partners. This strategic move strengthens Comac's presence in the European market, enhancing its services offered to small and medium-sized biopharmaceutical firms. ILIFE Consulting offers expertise in early-phase oncology and complex biotechnological clinical trials, which is expected to complement Comac's existing strengths and expand its market reach. The acquisition signifies Comac Medical’s ambition to establish a leading Pan-European presence as a full-service CRO, reinforcing its capabilities in delivering drug development services. Marina Iché, founder and CEO of ILIFE, continues in her leadership role while becoming a significant stakeholder in Comac, ensuring continuity of ILIFE's revered service and strategic direction. The acquisition is part of Comac Medical’s broader strategy of international expansion, which also includes recent leadership appointments to consolidate their market position.
Sectors
- Biotechnology and Pharmaceuticals
- Private Equity and Venture Capital
Geography
- United Kingdom – Comac Medical Group, the acquiring company, is based in the UK.
- France – ILIFE Consulting, the acquired company, is based in Paris, France.
Industry
- Biotechnology and Pharmaceuticals – The article discusses the acquisition of ILIFE Consulting, which is a Contract Research Organization (CRO) specializing in biotechnology and early-phase pharmaceutical trials.
- Private Equity and Venture Capital – EdgeCap Partners, a private equity firm, backs the expansion efforts of Comac Medical, enabling the acquisition of ILIFE Consulting.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Comac Medical Group | Acquiring Company | Company | A UK-based full-service Contract Research Organization specializing in drug development services. |
| ILIFE Consulting | Target Company | Company | A Paris-based CRO known for its expertise in early-phase oncology and complex biotechnological clinical trials. |
| EdgeCap Partners | Private Equity Backer | Company | A London and Tallinn-based private equity firm that supports Comac Medical's expansion strategy. |
| Marina Iché | CEO of ILIFE Consulting | Person | Founder and CEO of ILIFE Consulting, continuing in a leadership role post-acquisition. |
| Chris Smyth | CEO of Comac Medical Group | Person | Officials tasked with leading Comac Medical's expansion and integration of ILIFE Consulting. |